Delivery Order SPE2DB20D1109-SPE2DB25FP48R
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $1,953.40 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100 count). This firm fixed price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) with a ceiling value of $1,199.46. This firm fixed-price delivery order, which is set to be completed by July 30, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency awarded a Delivery Order valued at $1,940.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed price, non-set-aside contract was performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,066.74 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $10,468.50 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 25 mg capsules (100-count units). This firm fixed price, non-set-aside delivery order was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,389.74 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 20 mg capsules (100-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and has an ultimate completion date of July 24, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,966.33 for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on August 7, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP48RDelivery Order
The Defense Logistics Agency awarded a $1,452.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's SPE2DX prime contract vehicle functions as a comprehensive global pharmaceutical support mechanism enabling delivery of an extensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order represents one of numerous competitively awarded transactions under the IDC, demonstrating AmerisourceBergen's capability to fulfill varied federal medical supply requirements through open competition processes. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen alongside other potential contractors to serve Defense Health Agency, U.S. Coast Guard, and additional government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/30/25 |